← Back to Search

Other

Dry Needling for Knee Pain

N/A
Recruiting
Led By Matthew S Briggs, DPT, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-40 years-of-age
Presence of anterior knee pain around the patella during ascending/descending stairs, squatting, and/or running for at least 3 months.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and post testing (week 3)
Awards & highlights

Study Summary

This trial is testing if "dry needling" can help manage pain, muscle strength, and leg function for people with knee pain.

Who is the study for?
This trial is for individuals aged 18-40 with knee pain around the patella when doing activities like stairs, squatting, or running for at least 3 months. They must be referred for physical therapy and not currently receiving other treatments for knee pain. People can't join if they have bilateral knee syndrome, recent surgery or PT treatment, pregnancy, neurological conditions affecting movement, needle phobias, bleeding disorders, cancer diagnosis or systemic illnesses.Check my eligibility
What is being tested?
The study examines dry needling's effectiveness in managing knee pain and improving muscle strength and leg function. Participants will receive either actual dry needling or a sham (fake) procedure alongside their regular physical therapy to compare outcomes.See study design
What are the potential side effects?
Dry needling may cause some discomfort at the needle site, minor bleeding or bruising. Rarely it might lead to fatigue or dizziness immediately after treatment. Serious side effects are uncommon but could include infection at the puncture site.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 40 years old.
Select...
I have had knee pain near my kneecap when moving or squatting for over 3 months.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and post testing (week 3)
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and post testing (week 3) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change from Baseline Anterior Knee Pain Scale (AKPS) score to 3 weeks
Change from Baseline Numeric Pain Rating Scale (NPRS) score to 3 weeks
Secondary outcome measures
Change from Baseline Isometric knee and hip peak torque values to 3 weeks
Lysergic Acid Diethylamide
Change from Baseline Lower Extremity Functional Scale (LEFS) score to 3 weeks
+1 more

Trial Design

5Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Quad Dry NeedlingExperimental Treatment1 Intervention
Receives dry needling to their quadriceps muscles in addition to standard physical therapy treatment.
Group II: Glute Dry NeedlingExperimental Treatment1 Intervention
Receives dry needling to their gluteal muscles in addition to standard physical therapy treatment.
Group III: ControlActive Control1 Intervention
Receives only standard physical therapy treatment.
Group IV: Glute Sham Dry NeedlingPlacebo Group1 Intervention
Receives sham dry needling to their gluteal muscles in addition to standard physical therapy treatment.
Group V: Quad Sham Dry NeedlingPlacebo Group1 Intervention
Receives sham dry needling to their quadriceps muscles in addition to standard physical therapy treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dry Needling
2020
Completed Phase 2
~1090

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
829 Previous Clinical Trials
505,515 Total Patients Enrolled
1 Trials studying Patellofemoral Pain Syndrome
60 Patients Enrolled for Patellofemoral Pain Syndrome
Matthew S Briggs, DPT, PhDPrincipal InvestigatorThe Ohio State University Wexner Medical Center
1 Previous Clinical Trials
60 Total Patients Enrolled
1 Trials studying Patellofemoral Pain Syndrome
60 Patients Enrolled for Patellofemoral Pain Syndrome

Media Library

Dry Needling (Other) Clinical Trial Eligibility Overview. Trial Name: NCT02890485 — N/A
Patellofemoral Pain Syndrome Research Study Groups: Control, Glute Sham Dry Needling, Quad Sham Dry Needling, Quad Dry Needling, Glute Dry Needling
Patellofemoral Pain Syndrome Clinical Trial 2023: Dry Needling Highlights & Side Effects. Trial Name: NCT02890485 — N/A
Dry Needling (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02890485 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must be satisfied for one to qualify for enrollment in this research?

"The current medical research is targeting 120 individuals who suffer from patellofemoral pain and are between 18-40 years old. Specifically, applicants must meet the following requirements: meeting age criteria and referred for physical therapy treatment."

Answered by AI

Does this research endeavor have an age ceiling for participants?

"This investigation only admits individuals aged 18 to 40 years old. Other clinical trials exist for those under 18 and over 65, with 377 studies accommodating minors and 999 experiments fitting the needs of seniors."

Answered by AI

Are recruitment efforts ongoing for this investigation?

"As evidenced by clinicaltrials.gov, this medical experiment is searching for volunteers to participate. It was initially posted on August 1st 2016 and the page was most recently updated in April 22nd 2022."

Answered by AI

What is the end goal of this experiment?

"The primary evaluation metric for this clinical trial is the Change from Baseline Anterior Knee pain Scale (AKPS) score after 3 weeks. Secondary objectives include evaluating movement quality with a Lateral Step-Down Test, measuring pain sensitivity via Pressure Pain Threshold tests at 5 sites around the knee, and assessing patient's lower extremity functionality using Lower Extremity Functional Scales."

Answered by AI

How many subjects are participating in the current experiment?

"Affirmative. Per the clinicaltrials.gov records, this study is currently enrolling participants; commencing on August 1st 2016 and updated most recently on April 22nd 2022. This trial seeks 120 individuals across one medical centre."

Answered by AI
~4 spots leftby Aug 2024